Life Cycle Management Strategies - Optimizing revenues and defending generic competition
GBI Research’s latest report, "Life Cycle Management Strategies Optimizing revenues and defending generic competition" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.
Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.
Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=322850
Scope
- Introduction of LCM and product life cycle
- Objectives of LCM and factors impacting the choice of strategies
- LCM strategies depending on the way of approach
- Impact of LCM strategies on sales and growth trend of selected products
- Patent term extension and market exclusivity in the US and Europe
- LCM strategies of pipeline drugs of key players
- Keys to successful implementation of LCM strategies
- Identify the key LCM strategies used by most of the pharmaceutical companies
- Analyze the strategies to increase lifecycle and revenues of a drug
- Gain an understanding on the implementation of multiple strategies for a single product by including case studies
- Understand the operational pipeline strategies of key players
Executive Summary
- Introduction
- Overview of Product Life Cycle
- Product Life Cycle Curve
- Objectives of Life Cycle Management (LCM)
- Classification and Benefits of LCM Strategies
- Strategic Planning for LCM
- Factors Impacting Choice of LCM Strategies
- Developmental Strategies
- Indication Expansion/Sequencing and Repositioning
- Patient Subpopulations and Personalized Medicine
- Reformulation
- New Dosage Forms
- New Route of Administration
- Special Cases
- New Dosage Strengths and Regimen
- Fixed-Dose Combination and Co-packaging
- Next Generation Products and Modified Chemistry
- Metabolites
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease